Form 12b-25

                     U.S. SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20459

                                   FORM 12B-25

                           NOTIFICATION OF LATE FILING

                                   (Check One):
[  ] Form 10-K and 10-KSB  [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-QSB  [ ]Form N-SAR
      For Period Ended: June 30, 2002
      [ ] Transition Report on Form 10-K
      [ ] Transition Report on Form 20-F
      [ ] Transition Report on Form 11-K
      [ ] Transition Report on Form 10-Q
      [ ] Transition Report on Form N-SAR
      For the Transition Period Ended:


     Read Attached  Instruction  Sheet Before  Preparing  Form.  Please Print or
     Type.
     Nothing in this form shall be  construed to imply that the  Commission  has
     verified any information contained herein.

     If the  notification  related  to a portion of the  filing  checked  above,
     identify the Item(s) to which the notification relates:




Part I-Registrant Information


      MEDIX RESOURCES, INC.
      (Full name of Registrant)

--------------------------------------------------------------------------------
      420 LEXINGTON AVENUE, SUITE 1830
      (Address of Principal Executive Office)

--------------------------------------------------------------------------------
      NEW YORK, NEW YORK  10170
      (City State Zip)

Part II.Rules 12b.25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b.25(b), the following should
be completed. (Check box if appropriate)

     (a)  The reasons  described in  reasonable  detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;

X    (b)  The subject annual report,  semi-annual  report,  transition report on
          Form 10.K,  Form  10-KSB,  Form 20-F,  11.K or Form N.SAR,  or portion
          thereof  will  be  filed  on or  before  the  fifteenth  calendar  day
          following the prescribed due date; or the subject  quarterly report or
          transition report on Form 10.Q or Form 10-QSB, or portion thereof will
          be filed on or before the fifth  calendar day following the prescribed
          due date; and

     (c)  The accountant's statement or other exhibit required by Rule 12b.25(c)
          has been attached if applicable.



Part III. Narrative


State below in  reasonable  detail the  reasons why Form 10-K and 10-KSB,  20-F,
11-K, 10-Q and 10-QSB,  N-SAR or the transition  report or portion thereof could
not be filed within the prescribed time period.

     More time is needed to complete the  implementation of step one of SFAS No.
     142.


Part IV. Other Information

     (1)  Name and  telephone  number  of person  to  contact  in regard to this
          notification

          Mark W. Lerner                     (212)                   697-2509
              (Name)                      (Area Code)           (Telephone Number)

     (2)  Have all other periodic  reports required under section 13 or 15(d) of
          the  Securities  Exchange Act of 1934 or section 30 of the  Investment
          Company Act of 1940 during the preceding 12 months or for such shorter
          period that the  registrant  was required to file such  report(s) been
          filed? If the answer is no, identify report(s).  [X] Yes [ ] No

     (3)  Is it anticipated that any significant change in results of operations
          from  the  corresponding  period  for the  last  fiscal  year  will be
          reflected  by the  earnings  statements  to be included in the subject
          report or portion thereof? [ ] Yes [X] No

     If so, attach an explanation of the anticipated  change,  both  narratively
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

                              MEDIX RESOURCES, INC.

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date                           /s/ Mark W. Lerner, Executive Vice President

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

--------------------------------------------------------------------------------

          ATTENTION  Intentional  misstatements  or omissions of fact constitute
          Federal Criminal Violations (See 18 U.S.C. 1001).

--------------------------------------------------------------------------------